نتایج جستجو برای: cost cancer drugs (nhccd)

تعداد نتایج: 1470812  

Journal: :basic and clinical cancer research 0
mohammad reza rouhollahi cancer research center, cancer institute of iran, tehran university of medical sciences, tehran, iran samad mohammd nejad cancer model research center, cancer institute of iran, tehran university of medical sciences, tehran, iran iraj harirchi cancer research center, cancer institute of iran, tehran university of medical sciences, tehran, iran behrouz zarei corporate entrepreneurship department, university of tehran, tehran, iran. gelavizh keshtmand cancer research center, cancer institute of iran, tehran university of medical sciences, tehran, iran sanambar sadighi cancer research center, cancer institute of iran, tehran university of medical sciences, tehran, iran

introduction: allocation of the new (expensive) drugs for difficult refractory diseases and financial protection of the patients is an important challenge in the national health systems worldwide especially in developing countries.â  trastuzumab (herceptin) as one of the effective but expensive drugs, put major financial burden for the iranian patients and government. so the ministry of health ...

Journal: :international journal of health policy and management 2015
rajabali daroudi mehrzad mirzania kazem zendehdel

background although medical oncologists can have an important role in controlling the cost of cancer treatment, there is little information about their attitudes toward the cost of cancer treatment and the impact of cost on their treatment recommendations, especially in low- and middle-income countries (lmics). in this study, we assessed the attitude of iranian medical oncologists toward some e...

پایان نامه :دانشگاه آزاد اسلامی - دانشگاه آزاد اسلامی واحد تهران مرکزی - دانشکده علوم پایه 1389

nowadays, the development of anti cancer drugs is an important subject in pharmacology. bisphosphonates (b.p) are a great choice for design and production of the types of drugs which not only could perform as anti cancer agents but also could inhibit the function of acetyl cholinesterase (ache). ache hydrolyzes the acetylcholine (which is a neurotransmitter in nervous system) using the oh in i...

Amir Houshang Zargarzadeh, Farimah Rahimi, Fatemeh Jahani, Mohammadreza Amirsadri,

Background: Cancer is the third leading cause of death in Iran. Cancer treatment is very costly and chemotherapy drugs are one of the main causes of the high cost of cancer treatment. The purpose of this study was to evaluate the cost of chemotherapy drugs of five most common cancers and identifying the factors might affect the costs of chemotherapy drugs in a one of the large provinces of Iran...

Journal: :iranian journal of pediatric hematology and oncology 0
soheila zareifar hematology research center, pediatric hematology/oncology department, shiraz, iran parisa badiee alborzi clinical microbiology research center, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) pedram haddadi student research committee, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) babak abdolkarimi hematology research center, pediatric hematology/oncology department, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)

background: pediatric patients on chemotherapy are vulnerable to invasive fungal infection especially candida spices. resistance to antifungal agents has increased in candida spp., especially in non-albicans species. this study aims to assess the susceptibility of candida spp. strains isolated from children with acute leukemia less than 18 years. materials and methods: this prospective cross-se...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه صنعتی اصفهان - دانشکده شیمی 1390

abstract venlafaxine, 1–[2–(dimethylamino)–1–(4–methoxyphenyl) ethyl]cyclohexanol hydrochloride is a novel non-tricyclic antidepressant. venlafaxine is a second generation antidepressant drug, has a neuropharmacologic profile distinct from that of existing antidepressants including tricyclic compounds, selective serotonin reuptake inhibitors and monoamine oxidase inhibitors. venlafaxine impart...

Journal: :Mayo Clinic Proceedings 2016

Journal: :Journal of Biomedical and Pharmaceutical Research 2019

Journal: :Mayo Clinic Proceedings 2016

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید